Dr. Reddy’s Of India Buys GSK’s Oral Penicillin Brands, U.S. Plant
This article was originally published in PharmAsia News
India's Dr. Reddy's Laboratories has purchased the production facility for U.K.-based GlaxoSmithKline's oral penicillin along with rights to its product portfolio
You may also be interested in...
Coverage Decisions For AlloMap Molecular Testing To Detect Cardiac Allograft Rejections Left Up To MACs
The US CMS has proposed that due to low Medicare use, it will not nationally cover AlloMap molecular tests to detect cardiac allograft rejections.
Manufacturers considering use of the popular 99.99% germ-kill claim on hand sanitizer products should consult the Office of Compliance, said Division of Nonprescription Drug Products director Theresa Michele during a recent industry workshop. “Be very, very cautious about the claims you are making,” she said.
Change in leadership at the European Medicines Agency comes at a critical time.